B. Kingston (London, United Kingdom)
Author Of 1 Presentation
- B. Kingston (London, United Kingdom)
- R. Cutts (London, United Kingdom)
- M. Beaney (London, United Kingdom)
- G. Walsh-Crestani (London, United Kingdom)
- S. Hrebien (London, United Kingdom)
- L. Kilburn (London, United Kingdom)
- S. Kernaghan (London, United Kingdom)
- L. Moretti (London, United Kingdom)
- K. Wilkinson (London, United Kingdom)
- I. Macpherson (Glasgow, United Kingdom)
- R. Baird (Cambridge, Ca, United Kingdom)
- R. Roylance (London, United Kingdom)
- J. Reis-Filho (New York, NY, United States of America)
- M. Hubank (London, United Kingdom)
- I. Faull (Redwood City, CA, United States of America)
- K. Banks (Redwood City, CA, United States of America)
- I. Garcia-Murillas (London, United Kingdom)
- J. Bliss (London, United Kingdom)
- A. Ring (London, United Kingdom)
- N. Turner (London, United Kingdom)
99P - Analysis of ctDNA in advanced breast cancer reveals polyclonal disease associated with adverse outcome
Presenter Of 1 Presentation
- B. Kingston (London, United Kingdom)
- R. Cutts (London, United Kingdom)
- M. Beaney (London, United Kingdom)
- G. Walsh-Crestani (London, United Kingdom)
- S. Hrebien (London, United Kingdom)
- L. Kilburn (London, United Kingdom)
- S. Kernaghan (London, United Kingdom)
- L. Moretti (London, United Kingdom)
- K. Wilkinson (London, United Kingdom)
- I. Macpherson (Glasgow, United Kingdom)
- R. Baird (Cambridge, Ca, United Kingdom)
- R. Roylance (London, United Kingdom)
- J. Reis-Filho (New York, NY, United States of America)
- M. Hubank (London, United Kingdom)
- I. Faull (Redwood City, CA, United States of America)
- K. Banks (Redwood City, CA, United States of America)
- I. Garcia-Murillas (London, United Kingdom)
- J. Bliss (London, United Kingdom)
- A. Ring (London, United Kingdom)
- N. Turner (London, United Kingdom)